DermaSensor, Inc Announces Positive Results From Melanoma Clinical Validation Study of Skin Cancer Detection Device
DermaSensor’s optical spectroscopy and artificial intelligence technology demonstrated a 96% melanoma detection rate and a Negative Predictive Value of 98%. MIAMI, FL, U.S.A., March 29, 2022 /EINPresswire.com/ — DermaSensor Inc., a health technology company designing …